Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 815 results for "bristol myers squibb"

4 Momentum Stocks You Should Be Watching Right Now

4 Momentum Stocks You Should Be Watching Right Now

Here are four stocks in a range of industries with charts pointing to continued technical momentum. 1. Bristol-Myers Squibb Company (BMY - Get Report) has a beautiful long-term chart illustrating the rising channel of the last seven years. The ..., 1 hour ago

Eiger licenses lambda to investigate potential therapy for hepatitis delta

Eiger BioPharmaceuticals Inc. announced it licensed pegylated interferon lambda-1a to Bristol-Myers Squibb to investigate the efficacy and safety of the drug as a therapeutic option for the treatment of hepatitis delta virus infection. Eiger ...
 Healio40 minutes ago Eiger BioPharma licenses Bristol-Myers Squibb's Lambda  PharmaBiz6 days ago Eiger Bio linceses potential hepatitis delta therapeutic from Bristol-Myers Squibb  Seeking Alpha1 week ago Eiger BioPharmaceuticals Announces License of Worldwide Rights to Pegylated Interferon Lambda-1a from Bristol-Myers Squibb  Nasdaq1 week ago
Pharmaceutical Business Review

Recent Research Analysts Ratings Updates for Bristol-Myers Squibb (BMY)

Bristol-Myers Squibb (NYSE: BMY) recently received a number of ratings updates from brokerages and research firms: 4/27/2016 Bristol-Myers Squibb had its buy rating reaffirmed by analysts at Leerink Swann. 4/26/2016 Bristol-Myers Squibb had its ...
 American Banking News - Forex3 hours ago Bristol-Myers Q1 top line up 9%; EPS flat; earnings guidance raised; shares up 2% premarket  Seeking Alpha1 day ago Bokf Na Sells 1,778 Shares of Bristol-Myers Squibb Co (BMY)  Mideast Time16 hours ago Moors & Cabot Inc. Lowers Stake in Bristol-Myers Squibb Co (BMY)  Ticker Report16 hours ago

Bristol-Myers Squibb Company (BMY) Falls Further As It's Water-Logged And Getting Wetter

Trade-Ideas LLC identified Bristol-Myers Squibb Company ( BMY) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate. In addition to specific proprietary factors, Trade-Ideas ...
 TheStreet.com1 day ago Arterial Thrombosis Pipeline Report H1 2016 - Review of the Drug Profiles from Astellas Pharma, AstraZeneca, Bayer, Bristol-Myers Squibb, Eisai Co., Johnson & Johnson & Sanofi - Research and Markets  4 Traders5 hours ago Bristol-Myers Squibb Company Pipeline Review H1 2016  Empowered News9 hours ago Bristol-Myers Squibb Company - Product Pipeline Review - 2016  Global Information Inc1 day ago

Bristol-Myers 1Q Sales Jump but Costs Keep Its Profit Flat

Bristol-Myers Squibb Co. trounced Wall Street's first-quarter profit expectations as soaring sales of key new medicines offset higher expenses and a big hit from generic competition. Those factors left the drugmaker with a nearly flat profit, but ...
 ABC News1 day ago

Bristol-Myers Reaches Its Liftoff Moment

The price of Bristol-Myers Squibb (BMY) has been stuck in a broad sideways consolidation for more than a year, but it looks like liftoff time has finally arrived. In this daily chart of BMY, above, we can see the dips below $60 have been ...
 TheStreet.com1 day ago

Bristol-Myers Profit Beats Expectations, 2016 Guidance Raised

Bristol-Myers Squibb Co. reported first-quarter earnings that beat analysts predictions and raised its forecast for the year, as sales of key treatments like the cancer drug Opdivo and the blood thinner Eliquis rose. Profit excluding some items ...
 Bloomberg1 day ago Bristol raises 2016 forecast after first-quarter earnings beat  Sharenet1 day ago UPDATE 3-Bristol raises 2016 forecast after earnings beat  Reuters UK1 day ago

Bristol-Myers Squibb Earnings Overview

Background When Bristol-Myers merged with Squibb in 1989 to create the Bristol-Myers Squibb (NYSE: BMY ) with which we are familiar, it was the second-largest pharma company. Now it is a number of rungs down the list as measured either by sales ...
 Seeking Alpha1 day ago

Bristol-Myers tops Street 1Q forecasts

Bristol-Myers Squibb beats 1Q earnings and revenue expectations 9
 Yahoo! Finance1 day ago

BRIEF-Health Canada approves Opdivo for treatment of advanced or metastatic renal cell carcinoma

April 25 Bristol-Myers Squibb Canada * Bristol-Myers Squibb Canada says Health Canada approves Opdivo for treatment of advanced or metastatic renal cell carcinoma Source text for Eikon: Further company coverage: (Bengaluru Newsroom; +1 646 223 ...
 Reuters UK3 days ago Physician Views: Can Cabometyx compete with Opdivo in renal cell carcinoma?  FirstWord Pharma2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bristol myers squibb
Get updated on latest news & your favorite topics right in your inbox!
More     Less